TeselaGen

About:

TeselaGen Biotechnology develops DNA design and assembly tools for biology.

Twitter/X: teselagen

Top Investors: Propel(X), National Science Foundation, Endeavor Miami, Small Business Innovation Research, Taram Capital

Description:

TeselaGen Biotechnology develops DNA design and assembly tools for biology. It offers a cloud based solution for combinatorial gene design and editing. Its solutions include Graphical Sequence Editor to visualize, edit, and annotate gene and plasmid libraries; Symbolic CAD/CAM to piece together novel constructs using parts from its database; Fabrication Intelligence to generate protocols that are optimized for cost, and verified to assemble quickly and accurately; and Validation to align sequence traces with design variants. Michael Fero, Eduardo Abeliuk, and Nathan Hillson founded TeselaGen on June 1, 2011. It has its headquarters in San Francisco in California.

Total Funding Amount:

$4.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2011-06-01

Contact Email:

mike.fero(AT)teselagen.com

Founders:

Eduardo Abeliuk, Michael Fero, Nathan Hillson

Number of Employees:

1-10

Last Funding Date:

2023-08-24

IPO Status:

Private

Industries: